Literature DB >> 4149478

Failure of corticosteroid in the treatment of Duchenne (pseudo-hypertrophic) muscular dystrophy. Report of a clinically matched three year double-blind study.

I M Siegel, J E Miller, R D Ray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4149478

Source DB:  PubMed          Journal:  IMJ Ill Med J


× No keyword cloud information.
  6 in total

1.  Insights into bone health in Duchenne muscular dystrophy.

Authors:  Victor H Morgenroth; Lauren P Hache; Paula R Clemens
Journal:  Bonekey Rep       Date:  2012-02-01

Review 2.  Therapeutics in duchenne muscular dystrophy.

Authors:  Jonathan B Strober
Journal:  NeuroRx       Date:  2006-04

3.  Increased viability and differentiation of normal and dystrophic striated muscle in vitro.

Authors:  R J Walter; J Hyun
Journal:  In Vitro Cell Dev Biol       Date:  1986-09

Review 4.  Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy.

Authors:  Corrado Angelini; Enrico Peterle
Journal:  Acta Myol       Date:  2012-05

5.  Duchenne Muscular Dystrophy.

Authors:  Susan T. Iannaccone; Zohair Nanjiani
Journal:  Curr Treat Options Neurol       Date:  2001-03       Impact factor: 3.972

6.  Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial.

Authors:  Maggie C Walter; Peter Reilich; Simone Thiele; Joachim Schessl; Herbert Schreiber; Karlheinz Reiners; Wolfram Kress; Clemens Müller-Reible; Matthias Vorgerd; Peter Urban; Bertold Schrank; Marcus Deschauer; Beate Schlotter-Weigel; Ralf Kohnen; Hanns Lochmüller
Journal:  Orphanet J Rare Dis       Date:  2013-02-14       Impact factor: 4.123
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.